NCT06431737View on ClinicalTrials.gov

Comparison of Twice- and Four-times-daily Amoxicillin Administration in 2-week Tegoprazan-based H. Pylori Eradication

CompletedOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

August 31, 2024

Study Completion Date

December 31, 2024

Conditions

H.Pylori Infection

Interventions

DRUG

Amoxicillin

Tegoprazan 50 mg bid, amoxicillin 1000 mg bid or 500 mg qid, clarithromycin 500 mg bid for 14 days

Trial Locations (1)

Unknown

Soonchunhyang University Hospital, Seoul

All Listed Sponsors

lead

Soonchunhyang University Hospital

OTHER

NCT06431737 - Comparison of Twice- and Four-times-daily Amoxicillin Administration in 2-week Tegoprazan-based H. Pylori Eradication | Biotech Hunter | Biotech Hunter